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Pe r spe c t i v e
Mitochondria are the ubiquitous power units of animal 
cells, responsible for “oxphos,” the aerobic synthesis of 
most of the ATP that serves as the common coin of cel-
lular metabolism. To perform their primary task of oxi-
dative phosphorylation and to manage many secondary 
tasks, mitochondria use more than 1,000 proteins, of 
which fewer than 100 are involved directly in oxidative 
phosphorylation. The “secondary” tasks mitochondria 
perform include their own maintenance, calcium regu-
lation and signaling, lipid synthesis, and acting as gate-
keepers for programmed cell death. Catalyzed by the 
advances in knowledge and technology that underlie 
great progress in all areas of cell biology, mitochondrial 
physiology has been undergoing a renaissance. In this 
special issue of the Journal we highlight some examples 
of this renaissance, offering a series of Perspectives on 
Mitochondria. The purpose of the Perspectives in Gen-
eral Physiology is to provide a forum where scientific 
uncertainties or controversies are discussed in an au-
thoritative, yet open manner. This series had its origin 
in the 65th Annual Symposium of the Society of Gen-
eral Physiologists on “Mitochondrial Physiology and 
Medicine,” which took place in September 2011 in 
Woods Hole, MA. The meeting was organized by Shey-
Shing Sheu (Thomas Jefferson University) along with 
a committee comprising leaders in mitochondrial 
research, including Robert Balaban (NHLBI), Paolo 
Bernardi (University of Padova), Robert Dirksen (Uni-
versity of Rochester), Roberta Gottlieb (San Diego State 
University), Gyorgy Hajnóczky (Thomas Jefferson Uni-
versity), and Brian O’Rourke (Johns Hopkins Univer-
sity). A summary of the meeting was recently published 
(Sheu et al., 2011).
Mitochondrial proteomes
Mitochondria contain more than 1,000 proteins, of 
which only 13 are encoded by mitochondrial DNA. In 
their Perspective, Zhang et al. summarize recent ad-
vances in mitochondrial proteomics, including quanti-
fying “subproteomes” of the mitochondria devoted to 
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different cellular functions. The proteomes of mito-
chondria in various tissues (e.g., heart, muscle, brain) 
differ, and proteomic variation also causes or is associ-
ated with disease. Substantial differences, for example, 
exist between heart and liver mitochondrial proteomes 
that can be directly related to tissue-specific needs. Of 
particular medical importance are the distinct pro-
teomic features of mitochondria from healthy and dis-
eased cardiac myocytes. Another important and rapidly 
developing aspect of mitochondrial proteomics is the 
characterization of posttranslational modifications, some 
of which are dynamic and may play critical roles in mod-
ulating oxphos function on a subsecond scale (see next 
section). The key challenge, as articulated by Zhang 
et al., will be to translate the burgeoning mitochondrial 
proteomic databases into resources that can be readily 
tapped to advance our understanding of physiological 
function and pathophysiology.
Metabolic homeostasis of the heart
Nothing better illustrates the amazing capacity of mito-
chondria to meet the energy demands of tissue than 
their ability to power the cardiac contraction cycle 
throughout life, including workload increases of up to 
10-fold during surges in sympathetic activity, such as 
those that accompany the “fight or flight response.” 
Mitochondria perform this feat with very little change 
in the steady-state concentrations of key metabolites 
such as ATP, ADP, Pi, and NADH. A.V. Hill (1950) first 
noted the challenge posed by these facts, which he 
called “metabolic homeostasis.” In his Perspective, 
Robert Balaban takes up Hill’s challenge. Balaban mar-
shals evidence that posttranslational modifications of 
the F1F0 ATP synthase may underlie a 10-fold modula-
tion of the maximum rate of ATP production (qATPmax), 
and that calcium in the mitochondrial matrix is a major 
regulator of qATPmax. These ideas comprise an impor-
tant (although challenging to test) hypothesis that ties 
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will be needed to resolve the relationship between 
pHm transients and superoxide flashes, and their 
role(s) in regulating mitochondrial energy and ROS 
generation, both signals hold much promise in 
revealing dynamic details of mitochondrial function in 
living cells.
Mitochondrial calcium transport
The pivotal role of Ca2+ in regulating mitochondrial 
function and dysfunction is well recognized. The dogma 
for the mechanism of mitochondrial Ca2+ influx has 
been that it is determined primarily by the mitochon-
drial Ca2+ uniporter (MCU), whose molecular identity 
was recently revealed (Baughman et al., 2011; De Stefani 
et al., 2011). Several studies have identified additional 
Ca2+ uptake pathways, including a rapid mode of up-
take and the highly conserved mitochondrial protein 
leucine-zipper-EF-hand–containing transmembrane 
protein 1 (LETM1), which exhibit different Ca2+ affin-
ity, kinetics, and pharmacology from the MCU. The 
Perspective by O-Uchi et al. examines recent studies 
that have attempted to uncover the molecular identities 
of mitochondrial Ca2+ influx mechanisms using genetic 
manipulations, including small interfering RNA. O-Uchi 
et al. argue that it is reasonable to expect that different 
tissues may regulate mitochondrial Ca2+ influx in differ-
ent fashions, with different combinations and expression 
ratios of these channels and transporters, and point to 
studies that will clarify the diversity of Ca2+ influx mech-
anisms, explain how these Ca2+ transporters are regu-
lated by signaling molecules, and identify their distinct 
physiological functions and pathologies.
A hotly debated issue is whether LETM1 acts as a high 
affinity mitochondrial Ca2+ influx mechanism. The Per-
spective by Nowikovsky et al. summarizes current 
understanding of the molecular nature and of the 
physiology and pathophysiology of LETM1. LETM1 en-
codes a mitochondrial protein conserved throughout 
eukaryotes, both animals and plants. Its deletion is em-
bryonic lethal, and LETM1 mutations underlie the sei-
zure disorder known as Wolf–Hirschhorn syndrome. 
The protein was identified first as a mitochondrial 
K+–H+ antiporter, but has since been argued to function 
as a Ca2+–H+ antiporter by Jiang et al. (2009). Nowikovsky 
et al. make the case that the normal electrochemical 
gradients for H+ and Ca2+ would not allow LETM1 to act 
as a Ca2+ influx mechanism, but rather that the driving 
forces under physiological conditions favor LETM1 
serving as a Ca2+ efflux rather than influx mechanism.
Shape changing: Role of morphology in  
mitochondrial function
The idea that mitochondrial morphology is also a key 
regulator of mitochondrial function has recently gained 
much attention. The Perspective by Galloway and Yoon 
summarizes the current understanding of the interplay 
together several key aspects of mitochondrial physiology, 
including the roles of variations in matrix calcium over 
time and of matrix proteins regulated by calcium.
New insights from mitochondrial pH measurements
As articulated in Mitchell’s chemiosmotic theory, ATP 
synthesis in mitochondria is driven by the proton mo-
tive force, which consists of the chemical gradient for 
protons (pHm) and the mitochondrial membrane 
potential (m). Measurement of pHm has been a 
foundation of research in mitochondrial physiology. 
However, classical measurements were performed in 
bulk suspensions, disconnecting mitochondria from 
the milieu of the living cell, in which many natural and 
signal-dependent variations in pHi, Ca2+, and metabo-
lites to which mitochondria are sensitive occur. Geneti-
cally encoded (optogenetic) pH probes that promise to 
fill many gaps in the understanding of the chemios-
motic mechanism in living cells have recently been 
developed. In their Perspective, Santo-Domingo and 
Demaurex summarize recent research with mitochon-
drially targeted optogenetic pH probes, and, in particu-
lar, work they have done with a very promising probe, 
mito-SypHer. Using this probe they have observed spon-
taneous increases in pHm elevations that coincided with 
decreases in m in single mitochondria. Santo-Domingo 
and Demaurex propose that these spontaneous alkaliza-
tions of the mitochondrial matrix reflect intrinsic 
properties of the mitochondrial proton circuit that 
function to stabilize the proton motive force with op-
posing changes in m and pHm, and summarize the 
evidence that this stabilization process involves several 
distinct exchangers and symporters.
Superoxide flashes: Quantal production of reactive oxygen 
species (ROS)
Studying mitochondrial production of ROS has been 
challenging because of the limited methods capable of 
real-time monitoring of ROS levels in living cells and in 
situ. Recently, circularly permuted yellow fluorescent 
protein has been shown to specifically respond to super-
oxide. When targeted to the mitochondrial matrix, this 
probe detects bursts of superoxide production, called 
mitochondrial superoxide flashes (mSOFs), in individ-
ual mitochondria of intact quiescent cells. The Perspec-
tive of Wei and Dirksen provides an updated assessment 
of the mechanisms underlying mSOF generation and 
raises several controversies regarding the generation of 
mSOFs, including the relationship between mSOFs and 
pHm transients, the molecular identity of the large pore 
channel that opens during a flash event, and the se-
quence of events between pore opening and mSOF 
generation. Both mSOF and pHm signals require intact 
electron transport chain activities, because inhibition of 
any one of the electron transport complexes results in 
the abolition of the signals. Although future experiments 
 Sheu et al. 393
Mitochondrial antioxidants and scavenging of ROS
ROS are normally generated at very low levels by the 
mitochondrial respiratory chain but increase under 
conditions of stress, and can ultimately lead to tissue 
damage. In this issue, Aon et al. performed experiments 
and theoretical analyses to assess the relative contribu-
tion of glutathione (GSH) and thioredoxin (Trx), the 
two principal antioxidants in mitochondria, to the scav-
enging of H2O2, a major ROS. Their results show that 
the reactions governing the concentrations GSH and 
Trx are essential to maintaining minimal emission of 
H2O2 during high level respiration, and that the reac-
tions maintaining GSH and Trx work in close concert 
toward achieving this end.
Letters to the editor related to these Perspectives will 
be published in the September 2012 issue of the Journal. 
Letters to the editor should be received no later than 
Monday, July 16, 2012. The letters may be no longer 
than two printed pages (approximately six double-
spaced pages) and will be subject to editorial review. 
They may contain no more than one figure, no more 
than 15 references, and no significant references to un-
published work (and may not include supplemental 
material). Letters should be prepared according to the 
Journal’s instructions and can be submitted electroni-
cally at http://www.jgp.org. After the letters to the edi-
tor have been published, further responses are limited 
to full manuscripts.
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between mitochondrial form and function, with a specific 
focus on how disturbances of this interaction lead to meta-
bolic disease. This Perspective highlights the dynamic 
nature of the cross talk signaling between mitochon-
drial shape and metabolic activity. Well-orchestrated 
mitochondrial fission, fusion, and molecular motor–
based movement are necessary to ensure healthy bio-
energetics homeostasis.
Calcium buffering and calcium in cell death
The JGP is also publishing several primary articles in-
volving research on mitochondria presented at the 2011 
SGP Symposium. Two of these deal with calcium influx 
into mitochondria and its role in triggering cell death. 
In work presented in this issue, Wei et al. thoroughly 
characterized two distinct modes of Ca2+ uptake in car-
diac mitochondria, “MCUmode1” and “MCUmode2.” Mode 1 
has a relatively low capacity, is engaged by small (0.1–
0. 2-µM) increases in Ca2+, is completely inhibited by 
only relatively high levels (1 µM) of Ruthenium red 
(Ru360), and triggers relatively large changes in matrix 
free calcium. In contrast, mode 2 is responsible for the 
bulk of calcium transport for external calcium in the 
range of 2–10 µM, is inhibited by 0.1 µM Ru360, and is 
associated with very small changes in matrix free cal-
cium owing to very high buffering. The data and analy-
ses presented in this article support the conclusion that 
mode 1 calcium transport functions as a signal, perhaps 
to dynamically modulate oxidative phosphorylation (see 
Perspective by Balaban), whereas mode 2 is associated 
with a high capacity Ca2+-buffering function. The inves-
tigation of Wei et al. also indicates that the trigger for 
activation of the mitochondrial permeability transition 
pore (mPTP) is unlikely to be free matrix Ca2+ itself, but 
could be a downstream byproduct of total mitochon-
drial Ca2+ loading, a conclusion that dovetails nicely 
with work in another paper recently published in the 
JGP, by Seidlmayer et al. (2012).
Seidlmayer et al. (2012) quantified the inorganic 
polyphosphate (polyP) content of mitochondria (300 
pmol/mg of protein) in rabbit ventricular myocytes and 
manipulated polyP levels by means of a mitochondrially 
targeted polyphosphatase. Excess accumulation of Ca2+ 
in mitochondria is a key factor in triggering mPTP 
opening (and subsequent apoptosis) and consequent 
tissue damage such as occurs during cardiac ischemia 
reperfusion injury. Seidlmayer et al. (2012) found that 
depletion of polyP inhibited mPTP opening without 
affecting the matrix free calcium, and put forward the 
hypothesis that stable complexes of calcium with polyP 
act as triggers for mPTP opening. This is an important 
advance, which make a critical link between mito-
chondrial calcium influx, calcium buffering by polyP, 
and activation of the mPTP.
